Clinical Trials Logo

Filter by:
NCT ID: NCT04937894 Recruiting - Infectious Disease Clinical Trials

Antibiotic Therapy for Infectious Diseases

Start date: June 1, 2021
Phase:
Study type: Observational

Tigecycline is a last-resort antibiotic that is used to treat severe infections caused by extensively drug-resistant bacteria. However, the efficacy and safety data for tigecycline in infectious patients are lacking. The aim of this study is to assess the efficacy and safety of tigecycline in infectious patients using pharmacokinetics and omics.

NCT ID: NCT04937842 Recruiting - Solid Tumors Clinical Trials

Microtransplantation for Advanced and Relapsed Solid Tumors

Start date: June 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

In this study, we will apply micro transplantation to the field of solid tumors to study the efficacy and safety of radiotherapy and chemotherapy combined with micro transplantation in the treatment of advanced / relapsed solid tumors.

NCT ID: NCT04937699 Recruiting - Clinical trials for Acute Coronary Syndrome

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

MATE
Start date: March 28, 2023
Phase: Phase 4
Study type: Interventional

The MATE study is a randomized, multicenter, open-label, investigator-initiated clinical trial aimed to evaluate efficacy and safety of sequential monotherapy of ticagrelor and clopidogrel in patients with acute coronary syndrome (ACS) after coronary intervention. Standard DAPT of aspirin plus ticagrelor will be given for the first 1 month after PCI. After 1 month, event-free subjects will be randomized at 1:1 ratio into receiving standard DAPT (DAPT) until 12months , or switch to ticagrelor monotherapy for another 5 months , and further de-escalated to monotherapy of clopidogrel for the last 6 months(SAPT).

NCT ID: NCT04937517 Recruiting - ACL Injury Clinical Trials

ADC in Assessing Femoral Tunnel Position

Start date: May 25, 2021
Phase:
Study type: Observational

To examine the consistency between postoperative CT scan and intraoperative arthroscopic measurement in evaluating femoral tunnel position for anterior cruciate ligament (ACL)reconstruction,both using the apex of the deep cartilage(ADC)as the marker.

NCT ID: NCT04937387 Recruiting - Asthma Clinical Trials

Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Start date: July 29, 2021
Phase: Phase 3
Study type: Interventional

The study aims to evaluate the efficacy, safety and tolerability of FF/UMEC/VI compared with FF/VI via ELLIPTA® inhaler in Chinese participants with inadequately controlled asthma. ELLIPTA is a registered trademark of GlaxoSmithKline group of companies.

NCT ID: NCT04937283 Recruiting - Lung Adenocarcinoma Clinical Trials

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

This study aims to evaluate the non-inferiority in recurrence-free survival and overall survival of segmentectomy compared with lobectomy in patients with lung adenocarcinoma ≤ 2 cm with micropapillary and solid subtype negative by intraoperative frozen sections.

NCT ID: NCT04937192 Recruiting - Kidney Stone Clinical Trials

SNP-based Prediction of Recurrence Risk in Kidney Stone Patients

Start date: January 1, 2012
Phase:
Study type: Observational

The goal of this study is to gain new knowledge about genetic risk factors that may affect the kidney stone recurrence. The study seeks to understand if different forms of genes result in an increased risk of kidney stone recurrence.

NCT ID: NCT04937101 Recruiting - Clinical trials for Inflammatory Skin Disease

The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The treatment of chronic inflammatory skin diseases is a difficult point in clinical diseases, which mainly include patients with pathological scars, sarcoidosis and chronic eczema. Chronic nodular lesions and long-term itching symptoms bring great physical and mental pain to patients. Long-term repeated treatments are required. At present, the most commonly used treatment is intralesional injection of glucocorticoids. Long-term glucocorticoid injections have some side effects, including pain, hypopigmentation, skin atrophy, pigmentation, telangiectasia and menstrual disorders in women. There are a large number of clinical patients who still lack safe and effective drugs, including children, pregnant women, patients with weakened or defective immunity, and even patients with mild inflammatory skin diseases with mainly itching symptoms. The systemic and topical application of antihistamine drugs provides new ideas for the treatment of inflammatory skin. As the most commonly used clinical antihistamine, chlorpheniramine has a long history in the treatment of allergic diseases and can improve the body's inflammatory state. At the same time, the drug has high safety and is suitable for children and pregnant women, or patients with underlying diseases such as hypertension, diabetes, and immunodeficiency diseases.

NCT ID: NCT04936750 Recruiting - Clinical trials for Brief Description of Focus of Study

A One-arm, Prospective Study Comparing the Effects of Different Body Composition on the Survival of Patients Undergoing Radical Concurrent Chemoradiotherapy for Esophageal Cancer

Start date: June 17, 2021
Phase:
Study type: Observational

Skeletal muscle depletion and sarcopenia are the most typical features of cachexia, which occurs in 80% of patients with advanced esophageal cancer. Skeletal muscle consumption is an independent factor for poor prognosis, which negatively affects therapeutic toxicity, length of hospital stay, quality of life, complications, infection, and survival. The vast majority of patients had already experienced severe weight loss and skeletal muscle loss before the treatment began. During the concurrent chemoradiotherapy period, the intensity and long cycle of treatment, the toxic and side effects of treatment and the occurrence of radiation esophagitis would further lead to the increased demand for energy and decreased intake of patients, thus leading to continuous weight loss. Based on the previous literature, we suggest that baseline body composition has a significant impact on nutritional status, the incidence of adverse reactions, and survival during treatment. This research mainly for the thorough chemoradiation in patients with esophageal cancer, analysis treatment precursor composition, including skeletal muscle index, visceral fat area, body fat percentage and other parameters on the side reaction of chemoradiation, nutritional status and the influence of survival, and observe the baseline body composition and cure after 1 month of body composition changes of the impact on the survival time.

NCT ID: NCT04936347 Recruiting - Clinical trials for Intrauterine Adhesion

Hysteroscopic "Hot Knife" and "Cold Knife" in the Treatment of the Intrauterine Adhesion

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

In this prospective, randomized controlled trial,the investigators wish to explore the difference of therapeutic effect and prognosis between "hot knife" and "cold knife" in the treatment of uterine adhesion under hysteroscopy.